Felix Arellano | Global Head Pharmacovigilance and Drug Safety
Roche

Felix Arellano, Global Head Pharmacovigilance and Drug Safety, Roche

  Felix Arellano: Bio A graduate in medicine from Universidad Autonóma de Madrid, Spain, postgraduate studies in pharmacoepidemiology at Macgill University, Montreal, Canada and in pharmaceutical medicine (combined Strasbourg, Basel and Freiburg universities) Dr Arellano has more than 20 years of experience in the PV field in the pharmaceutical industry. A senior executive having worked in global roles for top 10 pharma in PV of medicines, consumer products, devices and vaccines Dr Arellano is now Global Head of Safety and Risk Management at F Hoffmann La Roche, Switzerland. With a career spanning all elements of PV Dr Arellano is committed to excellence in medical compliance and sees the potential for safety to move beyond that. His vision of safety at the heart of Roche’s success encompasses excellence in quality and compliance, being an agile and adaptive organization, smarter design and decision making throughout the product lifecycle and a patient centric safety risk management that creates value for society.

Appearances:



Day One World Drug Safety Congress EU 2018 @ 09:00

Innovation in PV

last published: 14/Aug/18 08:35 GMT

back to speakers